Abstract:Background: The Barthel Index dyspnea (BId) is responsive to physiological changes and pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD). However, the minimum clinically important difference (MCID) has not been established yet. Aim: To identify the MCID of BId in patients with COPD stratified according to the presence of chronic respiratory failure (CRF) or not. Materials and Methods: Using the Medical Research Council (MRC) score as an anchor, receiver operating characteri… Show more
“…On admission to TR, anthropometrics, clinical status and lung function were collected ( Table 1 ). On admission and discharge, 6MWT, 8 1 min Sit-to-Stand (1MSTS), 10 and Barthel Dyspnoea Index 11 were assessed. Program adherence (i.e.…”
mentioning
confidence: 99%
“… 10 Barthel dyspnoea improved in 83.3%, remaining unchanged in 16.7% of patients; in 50% of patients, the dyspnoea decrease was 6.5 points above the MCID. 11 …”
“…On admission to TR, anthropometrics, clinical status and lung function were collected ( Table 1 ). On admission and discharge, 6MWT, 8 1 min Sit-to-Stand (1MSTS), 10 and Barthel Dyspnoea Index 11 were assessed. Program adherence (i.e.…”
mentioning
confidence: 99%
“… 10 Barthel dyspnoea improved in 83.3%, remaining unchanged in 16.7% of patients; in 50% of patients, the dyspnoea decrease was 6.5 points above the MCID. 11 …”
“…The participants reported improvements in the mobility, self-care, and routine activity domains of the EQ-5D. The total and respiratory symptom domains of the CAT also improved in magnitude by more than the minimal clinically important difference (16). The CAT is a short, simple assessment tool for evaluating the symptom burden of COPD in daily clinical practice to check health status assessment and communicate between patients and healthcare providers.…”
Background: Home oxygen therapy is well known to improve survival among patients with severe chronic obstructive pulmonary disease (COPD). In Korea, home oxygen therapy has been reimbursed by national health care insurance since 2006. However, an adequate management strategy for home oxygen therapy is not yet established in Korea. This pilot study aimed to develop a new management strategy for home oxygen therapy.Methods: We developed a new home oxygen service strategy for COPD patients. The new strategy consists of patient education materials, "oxygen notes" for oxygen use self-monitoring, and provision of ambulatory oxygen. Using a structured questionnaire, we explored the usefulness of the new strategy and health status changes among patients before and after the study period.Results: Among 29 participants, the mean age was 69.6 years, and 62.1% were male. At the end of the study, the proportion of patients with severe dyspnea [modified Medical Research Council (mMRC) grade 4] decreased from 62.1% to 41.4%. The mean COPD assessment test score improved from 30.3 to 24.7, and 68.9% of patients scored above the minimum clinically important difference. The mean time and amount of ambulatory oxygen administration changed significantly by the end of the study. More than three-quarters of patients were satisfied with the educational material and oxygen note.
Conclusions:We showed that the new home oxygen service strategy improved the health status of COPD patients. Larger-scale and longer-term research to validate these results is warranted.
“…A reduction of 9 and 12 points is considered as the minimal clinically important difference in COPD patients without and with chronic respiratory failure, respectively. 26 Perceived health status was measured by the Euro Quality of Life Visual Analogue Scale. 27 Total scores range from 0 to 100 (higher scores represent better quality of life).…”
Objective: High prevalences of muscle weakness and impaired physical performance in hospitalized patients recovering from COVID-19-associated pneumonia have been reported. Our objective was to determine whether the level of exercise capacity after discharge would affect long-term functional outcomes in these patients. Methods: From three to five weeks after discharge from acute care hospitals (T0), patients underwent a six-minute walk test (6MWT) and were divided into two groups according to the distance walked in percentage of predicted values: <75% group and =75% group. At T0 and three months later (T1), patients completed the Short Physical Performance Battery and the Euro Quality of Life Visual Analogue Scale, and pulmonary function and respiratory muscle function were assessed. In addition, a repeat 6MWT was also performed at T1. Results: At T0, 6MWD values and Short Physical Performance Battery scores were lower in the <75% group than in the =75% group. No differences were found in the Euro Quality of Life Visual Analogue Scale scores, pulmonary function variables, respiratory muscle function variables, length of hospital stay, or previous treatment. At T1, both groups improved their exercise capacity, but only the subjects in the <75% group showed significant improvements in dyspnea and lower extremity function. Exercise capacity and functional status values returned to predicted values in all of the patients in both groups. Conclusions: Four weeks after discharge, COVID-19 survivors with exercise limitation showed no significant differences in physiological or clinical characteristics or in perceived health status when compared with patients without exercise limitation. Three months later, those patients recovered their exercise capacity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.